NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
16/06/2025
Voltar para busca
Dado oficial do USPTO
CSL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
08/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
15/09/2016
Data de registro
24/07/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/06/2025
Última transação
08/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
704
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Parkville, Victoria, AU
Examinador
NEHMER, JASON
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CSL Limited
Representantes
Scott D. Woldow Smith, Gambrell & Russell, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screeningblood groupingfor the typing and detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant compliment components and immunoglobulin subtypes; cell cultures and mediabiological preparations for use in cell cultures other than for medical and veterinary use; cell growth media for growing cells for use in scientific research; cell media for growing cells for use in scientific researchfor use in the production of pharmaceuticalsvaccinesmonoclonal antibodies and recombinant proteins; chemical test kits for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant compliment compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific purposes and for use in industry; chemical preparationsdiagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology in the nature of reagents for use in the preparation of invitro diagnostic kits; chemical preparationsmonoclonal antibodies for use in invitro scientific or research use; chemical preparations for industrial use for anti-body screeningblood groupingthe typing and detection of specific blood cells; diagnostic and testing agents for scientific or research usereagents for use in anti-body screeningblood grouping and the typing and detecting of specific blood cells; diagnostic reagents and preparations except for medical or veterinary use
Classe 5
Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disordersinfluenzarespiratory disease and disorders; pharmaceutical preparations and substances for the treatment and/or prevention of stroke or heart failure; vaccines; anti-virals; antigens for medical purposes; blood products in this classblood plasmareagent blood cells; products derived from blood and products derived from recombinant DNA technologyimmunoglobulinshuman albuminblood clotting factorsplasma volume expandersblood proteins for therapeutic use; serumsanti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits in the classinvitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substancesRhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparationsreagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparationsmonoclonal and polyclonal antibodies; pharmaceutical preparationsreagents for medical/clinical use for the typing and detection of specific blood cellsthe detection of relevant compliment components and immunoglobulin subtypes
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
16/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/03/2025
ES8R
TEAS SECTION 8 RECEIVED
19/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
24/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/12/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/12/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
24/07/2018
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
15/06/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
15/06/2018
IUCN
NOTICE OF ALLOWANCE CANCELLED
18/05/2018
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
18/05/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/11/2017
EX1G
SOU EXTENSION 1 GRANTED
17/11/2017
EXT1
SOU EXTENSION 1 FILED
17/11/2017
EEXT
SOU TEAS EXTENSION RECEIVED
17/11/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23/05/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/03/2017
PUBO
PUBLISHED FOR OPPOSITION
28/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
22/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/02/2017
ALIE
ASSIGNED TO LIE
02/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/12/2016
GNRT
NON-FINAL ACTION E-MAILED
27/12/2016
CNRT
NON-FINAL ACTION WRITTEN
27/12/2016
DOCK
ASSIGNED TO EXAMINER
21/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/09/2016
NWAP
NEW APPLICATION ENTERED
19/09/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CSL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.